Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)
The meeting was held in accordance with sections §§ 20 and 22 of the Act (2022:121) on temporary exceptions to facilitate the execution of general meetings in companies and other associations and the shareholders solely exercised their voting rights at the general meeting through voting in advance, so-called postal voting.The following resolutions were passed at the annual general meeting. Adoption of income statement and balance sheet for the financial year 2021 and discharge from liability The annual general meeting resolved to adopt the income statement and the consolidated income